Clinical Trials in Hot Springs, Arkansas

Find clinical trials in Hot Springs, Arkansas. Discover local research opportunities and treatment options in your area.

48 Active Trials Found in Hot Springs

Showing 48 trials on this page

Page 3 of 3

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

NCT ID: NCT04071457

This clinical trial, called S1803, is studying the effectiveness of two different treatments for patients with multiple myeloma (a type of blood cancer) after they have undergone a procedure called...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

NCT ID: NCT02734537

This clinical trial is exploring the effectiveness of radiation therapy, with or without the chemotherapy drug cisplatin, for patients who have stage III or IVA squamous cell carcinoma of the head ...

Recruiting

Phase: PHASE2 Conditions: Head and Neck Squamous Cell Carcinoma, Stage III Laryngeal Cancer AJCC v8 +14 more

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

NCT ID: NCT03937635

This clinical trial is studying how effective a combination of three medications—lenalidomide, dexamethasone, and daratumumab—are in treating patients with high-risk smoldering myeloma. Smoldering ...

Recruiting

Phase: PHASE3 Conditions: Smoldering Plasma Cell Myeloma

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

NCT ID: NCT04462406

The PET-Stop Trial is a study looking at how doctors can use special tests called biomarkers from PET/CT scans to decide if patients with advanced melanoma can safely stop their anti-PD-1 treatment...

Recruiting

Phase: PHASE2 Conditions: Advanced Melanoma, Unresectable Melanoma +9 more

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

NCT ID: NCT04566328

The EQUATE Trial is a research study looking at how effective a combination of four cancer-fighting drugs is for adults who have just been diagnosed with multiple myeloma, a type of blood cancer. T...

Recruiting

Phase: PHASE3 Conditions: Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma +1 more

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

NCT ID: NCT04597359

This clinical trial is investigating whether green tea catechins, which are natural compounds found in green tea, can help slow down the progression of prostate cancer in men who are being closely ...

Recruiting

Phase: PHASE2 Conditions: Prostate Carcinoma

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

NCT ID: NCT02201992

This clinical trial is studying a medication called crizotinib to see how well it works for patients with early-stage non-small cell lung cancer (NSCLC) that has been completely removed by surgery....

Recruiting

Phase: PHASE3 Conditions: Stage IIIA Non-Small Cell Lung Cancer AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7 +6 more

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

NCT ID: NCT06095583

This clinical trial is studying a new treatment approach for patients with limited-stage small cell lung cancer (LS-SCLC) who have responded well to initial chemotherapy and radiation therapy. The ...

Recruiting

Phase: PHASE3 Conditions: Limited-stage Small Cell Lung Cancer (LS-SCLC)

Search All Trials Browse All Locations